|
HBP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.365600E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.569000E-01 |
| Normal-vs-Stage2 |
3.437600E-01 |
| Normal-vs-Stage3 |
8.41400000000103E-05 |
| Normal-vs-Stage4 |
1.034940E-04 |
| Stage1-vs-Stage2 |
2.486400E-01 |
| Stage1-vs-Stage3 |
1.82262999999239E-05 |
| Stage1-vs-Stage4 |
2.48709999999264E-05 |
| Stage2-vs-Stage3 |
5.434200E-02 |
| Stage2-vs-Stage4 |
3.411700E-02 |
| Stage3-vs-Stage4 |
7.009800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.510100E-02 |
| Normal-vs-AfricanAmerican |
1.717420E-03 |
| Normal-vs-Asian |
9.196800E-01 |
| Caucasian-vs-AfricanAmerican |
5.146300E-02 |
| Caucasian-vs-Asian |
5.727400E-01 |
| AfricanAmerican-vs-Asian |
1.721830E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.614300E-02 |
| Normal-vs-Female |
3.083700E-02 |
| Male-vs-Female |
6.077600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.236000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.419600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.500900E-03 |
| Normal-vs-Age(81-100Yrs) |
3.072000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.991600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.738600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.217800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.585800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.190200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.988800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.007900E-02 |
| Normal-vs-Grade 2 |
5.699800E-01 |
| Normal-vs-Grade 3 |
2.078800E-03 |
| Normal-vs-Grade 4 |
1.00649999446034E-08 |
| Grade 1-vs-Grade 2 |
1.585230E-01 |
| Grade 1-vs-Grade 3 |
4.019500E-03 |
| Grade 1-vs-Grade 4 |
1.77248999999602E-05 |
| Grade 2-vs-Grade 3 |
2.835700E-04 |
| Grade 2-vs-Grade 4 |
3.87709997440311E-09 |
| Grade 3-vs-Grade 4 |
4.241400E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.314400E-02 |
| Normal-vs-ccB subtype |
1.390780E-04 |
| ccA subtype-vs-ccB subtype |
1.52580004186831E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.236840E-01 |
| Normal-vs-N1 |
2.675600E-02 |
| N0-vs-N1 |
6.775600E-02 |
|
|
